[1]
Fatmasari, N. et al. 2025. Design of Hydroxyxanthone Derivatives as Breast Cancer Inhibitors: A QSAR Modeling, Molecular Docking, Molecular Dynamics, MM-PBSA and ADMET Prediction. Journal of Multidisciplinary Applied Natural Science. 5, 3 (Jul. 2025), 783–798. DOI:https://doi.org/10.47352/jmans.2774-3047.283.